The Bayer company's aspirin patents are seized by the U.S., Canada, and European countries.
Date: 1917
The Office of Alien Property Custodian seizes the patents and sells them to a U.S. company, Sterling Drug, in response to Germany's role in World War I. The patent will be returned to Bayer in 1994.